uii skripsi evaluasi mutu fisik, 09613028 ade rachmah fitrianty 5238677224 abstract

Upload: anonymous-jxkgwbjer

Post on 17-Oct-2015

18 views

Category:

Documents


3 download

DESCRIPTION

b

TRANSCRIPT

  • xiii

    EVALUASI MUTU FISIK , UJI DISINTEGRASI DAN UJI DISOLUSI

    TERBANDING TABLET SALUT ENTERIK KETOPROFEN GENERIK

    DAN GENERIK BERMEREK

    INTISARI

    Ketoprofen merupakan salah satu obat anti inflamasi non steroid (AINS)

    yang memiliki kelarutan yang rendah dalam air dan memiliki permeabilitas

    tinggi dalam usus sehingga dikategorikan dalam Biopharmaceutical

    ClassificationSystem (BCS) kelas II. Obat ini tersedia dipasaran dalam berbagai

    sediaan generik dan bermerek, sehingga memungkinkan terjadi perbedaan

    formulasi dan metode fabrikasi. Penelitian ini bertujuan untuk mengevaluasi

    kesesuaian mutu fisik, kecepatan disintegrasi dan disolusi tablet salut enterik

    ketoprofen generik maupun generik bermerek yang beredar dengan standar yang

    telah ditetapkan. Penelitian ini menggunakan 5 produk ketoprofen 100 mg yang

    beredar dipasaran. Uji mutu fisik yang meliputi uji keseragaman bobot, diameter

    dan ketebalan serta uji disintegrasi dilakukan sesuai prosedur yang tertera dalam

    Farmakope Indonesia edisi III dan IV. Uji disintegrasi dilakukan dalam medium

    HCl 0,1N dan larutan dapar fosfat pH 6,8 pada suhu 370 2

    0C. Uji disolusi

    menggunakan alat disolusi tipe 2 (dayung), kecepatan rotasi 50 rpm dalam 900

    ml cairan simulasi usus pH 7,4 , dengan suhu pada 37 0,5 C selama 60 menit.

    Hasil penelitian menunjukkan bahwa uji mutu fisik dan uji disintegrasi secara

    keseluruhan memenuhi persyaratan dengan waktu hancur dalam larutan dapar

    fosfat pH 6,8 berkisar 12-18,77 menit (tidak lebih dari 2 jam). Persentase

    terdisolusi pada menit ke 45 (Q45) berturut-turut sebagai berikut : A= 101,68% ,

    B= 104,97%, C= 95,03%, D= 91,22%, E= 100,83 %. Hasil disolusi tersebut

    menunjukkan bahwa tablet ketoprofen telah memenuhi persyaratan disolusi

    USP30 NF-25 (tidak kurang dari 75%). Oleh karena itu dapat disimpulkan

    bahwa 5 tablet salut enterik yang beredar dipasaran telah memenuhi standar.

    Kata kunci : Ketoprofen, tablet, obat generik, BCS II, disolusi, Uji disolusi

    terbanding

  • xiv

    PHYSICAL QUALITY EVALUATION, DISINTEGRATION, AND

    COMPARATIVE DISSOLUTION TEST OF GENERIC AND BRANDED

    GENERIC KETOPROFEN ENTERIC COATED TABLETS

    ABSTRACT

    Ketoprofen is Non-Steroidal Antiinflamatory Drug (NSAID), which has

    low solubility in the water but high permeability in the intestine, thus ketoprofen

    is categorized in BCS class II. Ketoprofen is available in generic and branded

    generic products that might have differences in formulation and production

    method. This study was aimed to evaluate physical quality, disintegration and

    dissolution rates of generic and branded generic ketoprofen tablets in market. This

    study used 5 enteric coated ketoprofen products, which consists of one generic

    (code : A) and four branded generic products (Code : B,C,D,E). Physical quality

    tests were weight uniformity, diameter, thickness and disintegration tests

    according to the procedures of Indonesian Pharmacopoeia edition III and IV.

    Disintegration tests were performed using 0.1 N HCl and phosphate buffer

    solution pH 6.8 at 370 2

    0C. Dissolution tests were performed using a dissolution

    tester apparatus type 2 (paddle), speed rotsation of 50 rpm on 900 ml of

    simulation intestinal fluid without enzyme (pH 7.4), at 37 0.5 C in 60 minutes.

    The results of the physical quality and disintegration tests were compared with 3rd

    and 4th

    edition Indonesian Pharmacopoeia, while the dissolution tests were

    compared with USP 30 - NF25. The results showed that all physical quality tests

    and disintegration tests have fulfilled the requirements. The results of

    disintegration tests at phosphate buffer pH 6.8 is 12-18,7 minutes (less than 2

    hours). Drug release of all products at 45th

    minute (Q45) were 101,68%,104,97%,

    95,03%, 91,22%, 100,83% respectively, which complied with the USP in vitro

    dissolution specification. The results showed that dissolution test meet

    requirement of dissolution in USP30 NF-25 (not less than 75%). It indicated that

    five ketoprofen tablets that available in market have met the requirements.

    Keywords : ketoprofen, tablet, generic, BCS II, dissolution, comparative

    dissolution test